LIMITED POWER OF ATTORNEY
                           FOR SECTION 16(a) REPORTING

     KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
constitutes and appoints Friedhelm Blobel, Ph.D. and Wilson W. Cheung, and each
of them, as the undersigneds true and lawful attorney-in-fact
(the Attorney-in Fact), with full power of substitution and resubstitution, each
with the power to act alone for the undersigned and in the undersigneds name,
place and stead, in any and all capacities to:

     1.     prepare, execute, deliver and file with the United States Securities
and Exchange Commission, any national securities exchange and
SciClone Pharmaceuticals, Inc. (the Company) any and all reports
(including any amendment thereto) of the undersigned required or considered
advisable under Section 16(a) of the Securities Exchange Act of 1934, as amended
(the Exchange Act), and the rules and regulations thereunder, with respect to the
equity securities of the Company, including Form 3 (Initial Statement of Beneficial
Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership),
and Form 5 (Annual Statement of Changes in Beneficial Ownership); and

     2.     seek or obtain, as the undersigneds representative and on the
undersigneds behalf, information on transactions in the Companys equity securities
from any third party, including the Company, brokers, dealers, employee benefit
plan administrators and trustees, and the undersigned hereby authorizes any such
third party to release any such information to the Attorney-in-Fact.

     The undersigned acknowledges that:

     1.     this Limited Power of Attorney authorizes, but does not require, the
Attorney-in-Fact to act at his or her discretion on information provided to such
Attorney-in-Fact without independent verification of such information;

     2.     any documents prepared and/or executed by the Attorney-in-Fact on behalf
of the undersigned pursuant to this Limited Power of Attorney will be in such form
and will contain such information as the Attorney-in-Fact, in his or her discretion,
deems necessary or desirable;

     3.     neither the Company nor the Attorney-in-Fact assumes any liability for
the undersigneds responsibility to comply with the requirements of Section 16 of
the Exchange Act, any liability of the undersigned for any failure to comply with
such requirements, or any liability of the undersigned for disgorgement of profits
under Section 16(b) of the Exchange Act; and

     4.     this Limited Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigneds obligations under Section 16
of the Exchange Act, including, without, limitation, the reporting requirements
under Section 16(a) of the Exchange Act.

     The undersigned hereby grants to the Attorney-in-Fact full power and authority
to do and perform each and every act and thing requisite, necessary or convenient to
be done in connection with the foregoing, as fully, to all intents and purposes, as
the undersigned might or could do in person, hereby ratifying and confirming all
that the Attorney-in-Fact, or his or her substitute or substitutes, shall lawfully
do or cause to be done by authority of this Limited Power of Attorney.

     This Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 with respect to the
undersigneds holdings of and transactions in equity securities of the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Attorney-in-Fact.

     This Limited Power of Attorney shall be governed and construed in accordance
the laws of the State of California without regard to the laws that might otherwise
govern under applicable principles of conflicts of laws thereof.

     IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney
to be executed as of September 18, 2013.


Signature:     /s/ Nancy T. Chang
               ------------------
Print Name:    Nancy T. Chang